Uncovering axonal and synaptic pathological interplay in preclinical alzheimer's disease through organ-on-a-chip platforms
Ended Grant Awarded
- Award ID
- RAG098371UF7W86
- Recipient
-
Trustees Of Tufts College UEI C1F5LNUF7W86
- Awarding agency
-
National Institute on Aging
National Institutes of Health, Department of Health and Human Services
- Obligated
- -$659,999
Award facts
- Assistance listing
- 93.866 Aging Research
- Completion date
- Place of performance
- Boston, MA 02111, USA
Award details come from USAspending.gov.
Description
- Abstract
- Preclinical alzheimer's disease (ad) spans the two decades preceding the onset of clinical symptoms. Early intervention is essential for effective treatment; however, identifying the initial pathological signs of ad continues to be a significant challenge. One of the key early features of ad is axonopathy, characterized by morphological and functional changes in axonal structures that can be detected before other pathological signs appear. Due to their unique somatodendritic and axonal domains, axons rely on axonal transport (at) to maintain neuronal integrity. Disruptions in at are associated with preclinical ad and occur before well-established disease-related pathology emerges. Abnormal axonal structures associated with dysfunctional at are observed in the pre-plaque stages of ad, suggesting that early intervention targeting axonal dysfunction could offer new treatment opportunities before more advanced pathology develops. At is crucial for maintaining synaptic function. Research shows that uncontrolled synaptic damage in ad leads to axonal loss, which in turn, exacerbates synaptic decline. On the other hand, presynaptic maintenance depends on at for cargo delivery and clearance, suggesting that synaptic changes could stem from at deficits. This raises the critical question of whether axonal damage precedes or follows synaptic impairment in ad. Our project seeks to explore the hypothesis that axonopathy is an early event in ad independent of well-known disease-related pathology, such as plaques and tangles. We also intend to dissect the interplay between axonal and synaptic dysfunction in preclinical ad. Utilizing an innovative bioengineering-driven approach, we will employ microfluidic organ-on-a-chip platforms to examine axonal function in human neurons. Aim 1 will elucidate axonopathy and at dynamics in familial ad using induced pluripotent stem cell (IPSC)-derived microfluidic platforms. High-content imaging will be employed to identify early axonal phenotypes and assess dynamic changes in axonal homeostasis. Aim 2 will explore the interaction between axonal and synaptic pathology in familial ad by integrating IPSC technology with organ-on- a-chip microfluidic systems. By promoting synaptic compartmentalization, this aim will investigate axonopathy, at dynamics, and synaptic function to understand how axonal dysfunction affects pre- and postsynaptic terminals and their relation to axonal homeostasis. Aim 3 will detail the proteome of axonal and synaptic fractions in familial ad through an optimized microfluidic approach. The goal is to uncover dysregulated pathways and novel predictive biomarkers for early ad. This project will enhance our understanding of axonal dysfunction and its link to synaptic pathology, shedding light on early ad progression. This research will also contribute to identifying novel biomarkers and therapeutic targets for earlier detection and intervention, ultimately improving diagnosis and treatment strategies for ad. Furthermore, the insights gained could have broader implications for other neurodegenerative diseases where axonopathy plays a significant role, offering a new approach for identifying and targeting early disease processes across various conditions.
Quick answers
Who received award RAG098371UF7W86?
RAG098371UF7W86 was awarded to Trustees Of Tufts College by National Institute on Aging (National Institutes of Health) on November 11, 2026.
How much is award RAG098371UF7W86 worth?
Obligations on RAG098371UF7W86 net to -$659,999: more has been deobligated than obligated.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award